Health ❯ Medicine

Genetics

Gene Therapy Genetic Mutations Gene Mutations Mutations Gene Editing Genetic Disorders Genetic Risk Factors Neurodevelopmental Disorders Molecular Biology Epigenetics

APOE4 Triggers Vascular Scarring and Protein Build‑Up in Human Brain Models

Blocking TGF-β restored pericyte coverage in mice, signaling a preclinical path to target APOE4-driven vascular injury.

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

NTX-301 Reprograms Epigenetics to Fight Treatment-Resistant AML

Pope Leo XIV Reaffirms Jérôme Lejeune’s Legacy and Warns Against Algorithmic Medicine

Sloth Genome Reveals Ancient 'Jumping Genes' Linked to Slow Metabolism

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

Genetic Clues Help Explain GLP‑1 Differences in Results

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Five Protein Mutation Signatures Shape Tumor Immune Visibility

Largest Super-Ager Study Ties APOE Gene Variants to Alzheimer’s Resilience

Tau Neutralizes HSV-1 in Human Neuron Cultures, Pointing to Antiviral Roots of Alzheimer’s Features

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

Reactivated Fetal Gene Triggers Division of Adult Human Heart Cells in Lab

Mary‑Claire King Receives 2025 Princess of Asturias Prize for Scientific and Technical Research

MD Anderson Debuts PreCiSE, a Genome-Wide CRISPR Platform for Primary NK Cells

Polβ Repair Enzyme Found to Protect Developing Neurons From CpG-Linked DNA Mutations

PRMT5 and MAP Kinase Inhibitor Combo Drives Complete Tumor Regressions in Preclinical Models

EMA Recommends Restricted Approval for Eli Lilly’s Alzheimer’s Drug Kisunla

Celecoxib Reprograms Cancer Chromatin to Double Chemotherapy Efficacy in Mice

UCSF Model Maps Genetic Drivers of Tau Vulnerability and Resilience in Alzheimer’s